These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6411337)
1. Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. van Hazel GA; Scott M; Rubin J; Moertel CG; Eagan RT; O'Connell MJ; Kovach JS Cancer Treat Rep; 1983 Sep; 67(9):805-10. PubMed ID: 6411337 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mitomycin C in humans. den Hartigh J; McVie JG; van Oort WJ; Pinedo HM Cancer Res; 1983 Oct; 43(10):5017-21. PubMed ID: 6411336 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation]. Smolianskaia AZ; Spasibina TV Antibiotiki; 1984 May; 29(5):391-3. PubMed ID: 6430223 [TBL] [Abstract][Full Text] [Related]
4. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)]. Takahashi K; Yokoyama M; Takahashi H; Wakui A Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809 [TBL] [Abstract][Full Text] [Related]
5. [Blood levels of mitomycin C in patients given by various routes of administration]. Kato T; Hirai T; Yasui K; Nakazato H; Suzuki H Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2639-44. PubMed ID: 2505685 [TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors. Supko JG; Balcerzak SP; Kraut EH Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mitomycin C in dogs: application of a high-performance liquid chromatographic assay. Barbhaiya RH; Papp EA; Van Harken DR; Smyth RD J Pharm Sci; 1984 Sep; 73(9):1220-3. PubMed ID: 6436466 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
9. Distribution and excretion of 7-N-(p-hydroxyphenyl)-mitomycin C in normal mice. Imai R; Morimoto M; Marumo H Gan; 1982 Aug; 73(4):675-80. PubMed ID: 6818093 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung. Buice RG; Niell HB; Sidhu P; Gurley BJ Cancer Chemother Pharmacol; 1984; 13(1):1-4. PubMed ID: 6428762 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of vincristine sulfate in adult cancer patients. Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915 [TBL] [Abstract][Full Text] [Related]
12. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H; Mayer PR; Wajdula J; Fatenejad S J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mitomycin C in rabbit and human. van Hazel GA; Kovach JS Cancer Chemother Pharmacol; 1982; 8(2):189-92. PubMed ID: 6809356 [TBL] [Abstract][Full Text] [Related]
14. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893 [TBL] [Abstract][Full Text] [Related]
15. [Studies on the physiological disposition and pharmacokinetics of 7-N-(p-hydroxyphenyl)-mitomycin C]. Okumura S; Deguchi T; Nakamizo N Jpn J Antibiot; 1982 Aug; 35(8):1967-76. PubMed ID: 7154244 [TBL] [Abstract][Full Text] [Related]
17. Regional intra-arterial mitomycin C infusion in previously treated patients with metastatic colorectal cancer and concomitant measurement of serum drug level. Tseng MH; Luch J; Mittelman A Cancer Treat Rep; 1984 Nov; 68(11):1319-24. PubMed ID: 6437675 [TBL] [Abstract][Full Text] [Related]
18. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors. Chen HX; Marshall JL; Ness E; Martin RR; Dvorchik B; Rizvi N; Marquis J; McKinlay M; Dahut W; Hawkins MJ Clin Cancer Res; 2000 Apr; 6(4):1259-66. PubMed ID: 10778949 [TBL] [Abstract][Full Text] [Related]
19. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin. Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]